{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T14:17:21Z","timestamp":1792765041325,"version":"4.5.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.neurobiolaging.2012.04.012","type":"journal-article","created":{"date-parts":[[2012,5,11]],"date-time":"2012-05-11T11:02:12Z","timestamp":1336734132000},"page":"589-601","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Impairment of the septal cholinergic neurons in MPTP-treated A30P \u03b1-synuclein mice"],"prefix":"10.1016","volume":"34","author":[{"given":"\u00c9va M.","family":"Szeg\u0151","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiago F.","family":"Outeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawel","family":"Kermer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg B.","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib1","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1001\/archneur.60.3.387","article-title":"Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study","volume":"60","author":"Aarsland","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib2","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1152\/jn.1998.79.4.1633","article-title":"Loss of rhythmically bursting neurons in rat medial septum following selective lesion of septohippocampal cholinergic system","volume":"79","author":"Apartis","year":"1998","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib3","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1212\/WNL.0b013e3181b0bd3d","article-title":"Cholinergic denervation occurs early in Parkinson disease","volume":"73","author":"Bohnen","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib4","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1001\/archneur.60.12.1745","article-title":"Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study","volume":"60","author":"Bohnen","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib5","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1037\/0033-2909.114.1.80","article-title":"Context, time, and memory retrieval in the interference paradigms of Pavlovian learning","volume":"114","author":"Bouton","year":"1993","journal-title":"Psychol. Bull."},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib6","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib7","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","article-title":"Stages in the development of Parkinson's disease-related pathology","volume":"318","author":"Braak","year":"2004","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib8","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1212\/01.WNL.0000158422.41380.82","article-title":"Cognitive status correlates with neuropathologic stage in Parkinson disease","volume":"64","author":"Braak","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib9","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1006\/nlme.1997.3814","article-title":"Septal lesions impair the acquisition of a cued place navigation task: Attentional or memory deficit?","volume":"69","author":"Brandner","year":"1998","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib10","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/hipo.10160","article-title":"Impaired and spared cholinergic functions in the hippocampus after lesions of the medial septum\/vertical limb of the diagonal band with 192 IgG-saporin","volume":"14","author":"Chang","year":"2004","journal-title":"Hippocampus"},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib11","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1073\/pnas.97.2.571","article-title":"Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: Implications for pathogenesis and therapy","volume":"97","author":"Conway","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib12","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/mds.23592","article-title":"Characterizing Mild Cognitive Impairment in Parkinson's Disease","volume":"26","author":"Dalrymple-Alford","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib13","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1046\/j.1471-4159.1994.63062086.x","article-title":"Dopaminergic regulation of septohippocampal cholinergic neurons","volume":"63","author":"Day","year":"1994","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib14","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s12640-009-9091-4","article-title":"Neuroprotective effect of PACAP on translational control alteration and cognitive decline in MPTP parkinsonian mice","volume":"17","author":"Deguil","year":"2010","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib15","doi-asserted-by":"crossref","first-page":"6191","DOI":"10.1523\/JNEUROSCI.19-14-06191.1999","article-title":"Interactions between hippocampus and medial septum during sharp waves and theta oscillation in the behaving rat","volume":"19","author":"Dragoi","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib16","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa041470","article-title":"Rivastigmine for dementia associated with Parkinson's disease","volume":"351","author":"Emre","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib17","doi-asserted-by":"crossref","first-page":"S351","DOI":"10.1002\/mds.21683","article-title":"Cholinergic and other neurotransmitter mechanisms in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies","volume":"22","author":"Francis","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib18","doi-asserted-by":"crossref","first-page":"S351","DOI":"10.1002\/mds.21683","article-title":"Cholinergic and other neurotransmitter mechanisms in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies","volume":"22","author":"Francis","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib19","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.neurobiolaging.2006.06.013","article-title":"Age-dependent cognitive decline and amygdala pathology in alpha-synuclein transgenic mice","volume":"28","author":"Freichel","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib20","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00401-005-0004-1","article-title":"Depletion of cholinergic neurons in the nucleus of the medial septum and the vertical limb of the diagonal band in dementia with Lewy bodies","volume":"111","author":"Fujishiro","year":"2006","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib21","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2174\/156720510791050867","article-title":"Bridging Neurocognitive Aging and Disease Modification: Targeting Functional Mechanisms of Memory Impairment","volume":"7","author":"Gallagher","year":"2010","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib21a","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0306-4522(00)00385-7","article-title":"Pharmacological inactivation of the vesicular monoamine transporter can enhance 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of midbrain dopaminergic neurons, but not locus coeruleus noradrenergic neurons","volume":"101","author":"German","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib22","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0006-8993(98)00792-6","article-title":"Selective in vivo fluorescence labelling of cholinergic neurons containing p75(NTR) in the rat basal forebrain","volume":"808","author":"H\u00e4rtig","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib23","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1177\/33.2.2578498","article-title":"A modified histochemical technique to visualize acetylcholinesterase-containing axons","volume":"33","author":"Hedreen","year":"1985","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib24","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0169-328X(00)00015-2","article-title":"Dopamine D-5 receptor modulates hippocampal acetylcholine release","volume":"76","author":"Hersi","year":"2000","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib25","doi-asserted-by":"crossref","first-page":"6365","DOI":"10.1523\/JNEUROSCI.20-17-06365.2000","article-title":"Subcellular localization of wild-type and Parkinson's disease-associated mutant alpha -synuclein in human and transgenic mouse brain","volume":"20","author":"Kahle","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib26","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/S1474-4422(10)70212-X","article-title":"Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease","volume":"9","author":"Kehagia","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib27","doi-asserted-by":"crossref","first-page":"20049","DOI":"10.1073\/pnas.0706177104","article-title":"RET signaling does not modulate MPTP toxicity but is required for regeneration of dopaminergic axon terminals","volume":"104","author":"Kowsky","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib28","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1212\/WNL.56.10.1355","article-title":"Familial parkinsonism with synuclein pathology: clinical and PET studies of A30P mutation carriers","volume":"56","author":"Kr\u00fcger","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib29","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1111\/j.1460-9568.2006.05210.x","article-title":"Impairment of microtubule-dependent trafficking by overexpression of alpha-synuclein","volume":"24","author":"Lee","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib30","doi-asserted-by":"crossref","first-page":"10076","DOI":"10.1523\/JNEUROSCI.0618-11.2011","article-title":"\u03b1-Syn suppression reverses synaptic and memory defects in a mouse model of dementia with Lewy bodies","volume":"31","author":"Lim","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib31","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.expneurol.2009.10.005","article-title":"Forebrain overexpression of alpha-synuclein leads to early postnatal hippocampal neuron loss and synaptic disruption","volume":"221","author":"Lim","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib32","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/hipo.1071","article-title":"Storage, recall, and novelty detection of sequences by the hippocampus: Elaborating on the SOCRATIC model to account for normal and aberrant effects of dopamine","volume":"11","author":"Lisman","year":"2001","journal-title":"Hippocampus"},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib33","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1001\/archneur.1995.00540310069018","article-title":"The frequency and associated risk factors for dementia in patients with Parkinson's disease","volume":"52","author":"Marder","year":"1995","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib34","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1523\/JNEUROSCI.08-08-02804.1988","article-title":"Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal","volume":"8","author":"Maroteaux","year":"1988","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib35","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s004010051064","article-title":"Neuritic degeneration in the hippocampus and amygdala in Parkinson's disease in relation to Alzheimer pathology","volume":"98","author":"Mattila","year":"1999","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib36","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/S0140-6736(00)03399-7","article-title":"Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study","volume":"356","author":"McKeith","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib37","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium","volume":"65","author":"Mckeith","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib38","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/mds.22735","article-title":"Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease","volume":"25","author":"Moro","year":"2010","journal-title":"Mov Disord."},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib39","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/297681a0","article-title":"Place navigation impaired in rats with hippocampal lesions","volume":"297","author":"Morris","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib40","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/ana.410430612","article-title":"Hereditary form of parkinsonism\u2014dementia","volume":"43","author":"Muenter","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib41","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.pnpbp.2009.03.039","article-title":"The septo-hippocampal system, learning and recovery of function","volume":"33","author":"Niewiadomska","year":"2009","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib42","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jns.2010.01.013","article-title":"The effect of dopamine agonists: the expression of GDNF, NGF, and BDNF in cultured mouse astrocytes","volume":"291","author":"Ohta","year":"2010","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib43","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.2174\/138161209789649321","article-title":"Current and future therapeutic strategies for Parkinson's disease","volume":"15","author":"Outeiro","year":"2009","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib44","series-title":"Maps and Guide to Microdissection of the Rat Brain","author":"Palkovits","year":"1988"},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib45","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2001"},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib46","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1136\/jnnp.48.5.413","article-title":"Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease","volume":"48","author":"Perry","year":"1985","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib47","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/00001756-199403000-00002","article-title":"Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease","volume":"5","author":"Perry","year":"1994","journal-title":"Neuroreport"},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib48","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1093\/brain\/awh571","article-title":"Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up","volume":"128","author":"Rodriguez-Oroz","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib49","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0304-3940(80)90314-6","article-title":"Origin of dopaminergic innervation of the rat hippocampal formation","volume":"18","author":"Scatton","year":"1980","journal-title":"Neurosci. Lett."},{"issue":"7 Suppl","key":"10.1016\/j.neurobiolaging.2012.04.012_bib50","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1601-183X.2007.00378.x","article-title":"Neurotrophic factors in Alzheimer's disease: role of axonal transport","volume":"1","author":"Schindowski","year":"2008","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib51","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1002\/mds.23043","article-title":"Two Parkinson's Disease Patients With alpha-Synuclein Gene Duplication and Rapid Cognitive Decline","volume":"25","author":"Shin","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib52","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1196\/annals.1332.016","article-title":"The role of alpha-synuclein in both neuroprotection and neurodegeneration","volume":"1035","author":"Sidhu","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib53","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1091\/mbc.e08-03-0302","article-title":"{alpha}-synuclein and its A30P mutant affect actin cytoskeletal structure and dynamics","volume":"20","author":"Sousa","year":"2009","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib54","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/ana.67","article-title":"Clinical and pathological features of a Parkinsonian syndrome in a family with an Ala53Thr alpha-synuclein mutation","volume":"49","author":"Spira","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib55","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1146\/annurev.neuro.27.070203.144130","article-title":"The medial temporal lobe","volume":"27","author":"Squire","year":"2004","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib56","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1523\/JNEUROSCI.0222-06.2006","article-title":"Estrogen induces estrogen receptor alpha-dependent cAMP response element-binding protein phosphorylation via mitogen activated protein kinase pathway in basal forebrain cholinergic neurons in vivo","volume":"26","author":"Szeg\u0151","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib57","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1159\/000321119","article-title":"Effects of estrogen on beta-amyloid-induced cholinergic cell death in the nucleus basalis magnocellularis","volume":"93","author":"Szeg\u0151","year":"2011","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib58","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jns.2011.06.048","article-title":"Dopamine-depletion and increased \u03b1-synuclein load induce degeneration of cortical cholinergic fibers in mice","volume":"310","author":"Szeg\u0151","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib59","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.nbd.2011.09.017","article-title":"A30P \u03b1-synuclein impairs dopaminergic fiber regeneration and interacts with L-DOPA replacement in MPTP-treated mice","volume":"45","author":"Szeg\u0151","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib60","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/dneu.20768","article-title":"Understanding proneurotrophin actions: Recent advances and challenges","volume":"70","author":"Teng","year":"2010","journal-title":"Dev. Neurobiol."},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib61","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1212\/WNL.54.2.407","article-title":"Cholinergic dysfunction in diseases with Lewy bodies","volume":"54","author":"Tiraboschi","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib62","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.tins.2010.09.004","article-title":"\u03b1-Synuclein and dopamine at the crossroads of Parkinson's disease","volume":"33","author":"Venda","year":"2004","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib63","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jchemneu.2010.12.003","article-title":"Different sub-cellular localization of alpha-synuclein in the C57BL\\6J mouse's central nervous system by two novel monoclonal antibodies","volume":"41","author":"Vivacqua","year":"2011","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib64","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1017\/S1355617703910022","article-title":"Prodromal frontal\/executive dysfunction predicts incident dementia in Parkinson's disease","volume":"9","author":"Woods","year":"2003","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib65","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/(SICI)1096-9861(19961028)374:4<535::AID-CNE5>3.0.CO;2-2","article-title":"Direct catecholaminergic-cholinergic interactions in the basal forebrain","volume":"374","author":"Zaborszky","year":"1996","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2012.04.012_bib66","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ana.10795","article-title":"The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia","volume":"55","author":"Zarranz","year":"2004","journal-title":"Ann. Neurol."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458012002606?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458012002606?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:22:14Z","timestamp":1759317734000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458012002606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":67,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S0197458012002606"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2012.04.012","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impairment of the septal cholinergic neurons in MPTP-treated A30P \u03b1-synuclein mice","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2012.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}